MRNA earnings date and last-quarter result: next report 2026-07-31, last quarter beat, P/E -7.13. Updated 2026-07-23.
Moderna (MRNA) Research Hub
Moderna (MRNA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 198.85 USD (-0.62%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -7.13, market cap 23.26B. This hub links to the full technical, earnings and options research available for MRNA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 198.85 USD (-0.62%) |
| 52-week range | 49.84 USD – 254.48 USD |
| Trend regime | Range |
| 14-day RSI | 53.5 (Neutral) |
| Trailing P/E | -7.13 |
| Market cap | 23.26B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-31 |
Available research for MRNA
Covered Call on MRNA: how it works, illustrative setup around the real 198.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MRNA: how it works, illustrative setup around the real 198.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MRNA: how it works, illustrative setup around the real 198.85 USD price, max profit/loss, breakeven and when to use it. Educational.
MRNA technical analysis: range, last 198.85 USD, RSI 53.5, 52w range 49.84 USD–254.48 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is MRNA in?
Moderna (MRNA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MRNA in an uptrend or downtrend?
As of 2026-10-26, MRNA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MRNA's trailing P/E ratio?
MRNA's trailing P/E is -7.13, with a market cap of 23.26B. See the earnings research page for full valuation detail.
When does MRNA next report earnings?
MRNA is next scheduled to report earnings on 2026-07-31.